The companies’ violations caused extensive losses to Nasser Institute for Research and Treatment and the National Heart Institute, according to the competition authority The Egyptian Competition Authority announced on Wednesday that it has referred seven major medical supply companies to the public prosecutor—claiming the companies had manipulated government tenders. The authority added in a statement …